Cargando…
Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer
The vast majority of studies investigating immune checkpoint inhibition (ICI) in patients with breast cancer have focused on triple-negative breast cancer (TNBC). In this study, we compared the tumor immune microenvironment (TIME) between TNBC and hormone receptor-negative HER2-positive breast cance...
Autores principales: | Vos, Hanne, Lambein, Kathleen, Richard, François, Mariën, Bram, Nevelsteen, Ines, Punie, Kevin, Wildiers, Hans, Berben, Lieze, Laenen, Annouschka, Floris, Giuseppe, Desmedt, Christine, Smeets, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460670/ https://www.ncbi.nlm.nih.gov/pubmed/34556657 http://dx.doi.org/10.1038/s41523-021-00332-7 |
Ejemplares similares
-
Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer
por: Izci, Hava, et al.
Publicado: (2022) -
Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer
por: Berben, Lieze, et al.
Publicado: (2020) -
Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer
por: Lambrechts, Yentl, et al.
Publicado: (2023) -
Oncological safety of autologous breast reconstruction after mastectomy for invasive breast cancer
por: Geers, Joachim, et al.
Publicado: (2018) -
Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy
por: Dalmasso, Bruna, et al.
Publicado: (2018)